Good News for Older Patients with Lung Cancer
Post-surgery survival rates for older patients with lung cancer may be improving, a new study found.
A New Job for Gilotrif
The US Food and Drug Administration has approved Gilotrif (afatinib) to treat squamous cell lung cancer.
A New Job for Xalkori
The US Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat patients with advanced non-small cell lung cancer (NSCLC) who have tumors with an ROS-1 gene alteration.
Is a PET Scan the Right Option for You?
For cancer survivors, vigilance is a key part of remaining cancer free. But new evidence suggests one cancer detection tool is being overused — and that isn’t helping anyone.
Melanoma Rx May Treat Lung Cancer, Too
Turns out a melanoma medication could also help patients with a different type of cancer.
New Guidelines for Smokers' Health Care
Smoking has been tied to numerous health issues. Now an expert panel has made recommendations for doctors who care for adults and pregnant women who smoke.
How Ethnicity Affects Cancer Risk
Your ethnicity may be a factor in your cancer risk.
Smoking Might Be Even More Dangerous Than You Think
There are countless reasons to quit smoking. And new data may add 12 more reasons to the list.
Lung Cancer Rx Might Outperform Chemo
When you're sick, you may feel like the immune system is a weak tool for protecting the body. But new evidence is showing how medications might activate the immune system to treat a very serious illness — lung cancer.
Prevention Key as Cancer Rates Rise
You'd be hard-pressed to find a person who didn't know anyone affected by cancer. New evidence is highlighting just how widespread the disease is — and what can be done to stop it.